ARTICLE | Clinical News
Incyte Pharmaceuticals Inc. regulatory update
May 2, 1994 7:00 AM UTC
IPI (Palo Alto) this week is to receive U.S. Patent No. 5,308,834 covering the use of bactericidal/permeability-increasing protein, its lead biotherapeutic, and fragments thereof, in the treatment of ...